“Evaluation of the Inhibitory Effect of 2,5-Dimethyl-Celecoxib on Tamoxifen-Sensitive and -Resistant Human Breast Cancer Cells (MCF-7)”. Clinical Medicine and Pharmacology, vol. 3, no. 1, Jan. 2026, https://doi.org/10.70731/sh45n436.